29824 Federal Register / Vol. 66, No. 106 / Friday, June 1, 2001 / Notices

Form No.: 10008 (OMB# 0938–0807).

Use: This survey is necessary to

collect access, quality, and diversity of

product selection information from

beneficiaries. These key elements of the

evaluation cannot be thoroughly

evaluated without a beneficiary survey.

The information will be presented to

HCFA and to Congress, who will use the

results to determine whether the

demonstration should be extended to

other sites.

Frequency: Annually;

Affected Public: Individuals or

households;

Number of Respondents: 2,500;

Total Annual Responses: 2,500;

Total Annual Hours: 725.

To obtain copies of the supporting

statement for the proposed paperwork

collections referenced above, access

HCFA’s WEB SITE ADDRESS at http://

www.hcfa.gov/regs/prdact95.htm, or Email your request, including your

address and phone number, to

Paperwork@hcfa.gov, or call the Reports

Clearance Office on (410) 786–1326.

Written comments and

recommendations for the proposed

information collections must be mailed

within 30 days of this notice directly to

the OMB Desk Officer designated at the

following address: OMB Human

Resources and Housing Branch,

Attention: Allison Eydt, New Executive

Office Building, Room 10235,

Washington, D.C. 20503.

Dated: May 17, 2001.

John P. Burke, III,

HCFA Reports Clearance Officer, HCFA,

Office of Information Services, Security and

Standards Group, Division of HCFA

Enterprise Standards.

[FR Doc. 01–13760 Filed 5–31–01; 8:45 am]

BILLING CODE 4120–03–P

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

Health Care Financing Administration

[Document Identifier: HCFA–2728]

Agency Information Collection

Activities: Submission For OMB

Review; Comment Request

In compliance with the requirement

of section 3506(c)(2)(A) of the

Paperwork Reduction Act of 1995, the

Health Care Financing Administration

(HCFA), Department of Health and

Human Services, has submitted to the

Office of Management and Budget

(OMB) the following proposal for the

collection of information. Interested

persons are invited to send comments

regarding the burden estimate or any

other aspect of this collection of

information, including any of the

following subjects: (1) The necessity and

utility of the proposed information

collection for the proper performance of

the agency’s functions; (2) the accuracy

of the estimated burden; (3) ways to

enhance the quality, utility, and clarity

of the information to be collected; and

(4) the use of automated collection

techniques or other forms of information

technology to minimize the information

collection burden.

Type of Information Collection

Request: Extension of a previously

approved collection;

Title of Information Collection: End

Stage Renal Disease Medical Evidence

Report Medicare Entitlement and/or

Patient Registration and Supporting

Regulations in 42 CFR, 405.2133;

Form No.: HCFA–2728 (OMB# 0938–

0046);

Use: To capture the necessary medical

information required to determine

Medicare eligibility of an end stage

renal disease claimant. It also captures

the specific medical data required for

research and policy decisions on this

population as required by law;

Frequency: weekly, monthly,

quarterly, semi-annually, and annually;

Affected Public: Individuals or

households, business or other for profit,

not-for-profit institutions;

Number of Respondents: 60,000;

Total Annual Responses: 60,000;

Total Annual Hours: 25,000.

To obtain copies of the supporting

statement for the proposed paperwork

collections referenced above, access

HCFA’s WEB SITE ADDRESS at http://

www.hcfa.gov/regs/prdact95.htm, or Email your request, including your

address and phone number, to

Paperwork@hcfa.gov, or call the Reports

Clearance Office on (410) 786–1326.

Written comments and

recommendations for the proposed

information collections must be mailed

within 30 days of this notice directly to

the OMB Desk Officer designated at the

following address: OMB Human

Resources and Housing Branch,

Attention: Allison Eydt, New Executive

Office Building, Room 10235,

Washington, D.C. 20503.

Dated: May 17, 2001.

John P. Burke, III,

HCFA Reports Clearance Officer, HCFA Office

of Information Services, Security and

Standards Group, Division of HCFA

Enterprise Standards.

[FR Doc. 01–13761 Filed 5–31–01; 8:45 am]

BILLING CODE 4120–03–P

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

Health Care Financing Administration

[HCFA–3071–N]

Medicare Program; Meeting of the

Drugs, Biologics, and Therapeutics

Panel of the Medicare Coverage

Advisory Committee—June 20, 2001

AGENCY: Health Care Financing

Administration (HCFA), HHS.

ACTION: Notice of meeting.

SUMMARY: This notice announces a

public meeting of the Drugs, Biologics,

and Therapeutics Panel (the Panel) of

the Medicare Coverage Advisory

Committee. The Panel provides advice

and recommendations to us about

clinical issues. The Panel will hear and

discuss presentations from interested

persons regarding the use of levocarnitine in end stage renal disease

patients.

Notice of this meeting is given under

the Federal Advisory Committee Act (5

U.S.C. App. 2, section 10(a)(1) and

(a)(2)).

DATES: The Meeting: June 20, 2001 from

8 a.m. until 4:30 p.m. E.D.T.

Deadline for Presentations and

Comments: June 13, 2001, 5 p.m., E.D.T.

Special Accommodations: Persons

attending the meeting who are hearing

or visually impaired, or have a

condition that requires other special

assistance or accommodations, are

asked to notify the Executive Secretary

by June 6, 2001 (see FOR FURTHER

INFORMATION CONTACT).

ADDRESSES: The Meeting: The meeting

will be held at The Baltimore

Convention Center, Rooms 321 and 322,

One West Pratt Street, Baltimore, MD

21201.

Presentations and Comments: Submit

formal presentations and written

comments to Kimberly A. Long,

Executive Secretary; Office of Clinical

Standards and Quality; Health Care

Financing Administration; 7500

Security Boulevard; Mail Stop S3–02–

01; Baltimore, MD 21244.

Website: You may access up-to-date

information about this meeting at

www.hcfa.gov/coverage.

Hotline: You may access up-to-date

information about this meeting on the

HCFA Advisory Committee Information

Hotline, 1–877–449–5659 (toll free) or

in the Baltimore area (410) 786–9379.

FOR FURTHER INFORMATION CONTACT:

Kimberly A. Long, Executive Secretary,

410–786–5702.

SUPPLEMENTARY INFORMATION: On August

13, 1999, we published a notice (64 FR